View Older Stories View More Recent Stories

Apr 21, 2020 08:17AM Genprex Appoints Shannon Inman as Vice President of Global Clinical Operations
Mar 24, 2020 08:17AM Genprex Bolsters Board of Directors, Appoints Three Biotechnology and Healthcare Industry Leaders
Mar 23, 2020 08:17AM Genprex Strengthens Leadership Team with the Appointment of Two Accomplished Life Science Executives
Mar 5, 2020 08:05AM Lead Researcher Behind Genprex’s Diabetes Gene Therapy Featured in New Video Interview
Mar 4, 2020 08:00AM Genprex to Present at the 2020 LD Micro Virtual Conference
Mar 3, 2020 08:17AM Genprex to Present at the 2020 LD Micro Virtual Conference
Feb 21, 2020 04:15PM Genprex, Inc. Announces Closing of $17,500,000 Common Stock Offering At-The-Market and Without Warrants
Feb 19, 2020 09:23AM Genprex (GNPX) Prices 5M Shares at $3.50
Feb 19, 2020 09:23AM Genprex, Inc. Prices $17,500,000 Common Stock Offering Priced At-The-Market and Without Warrants
Feb 11, 2020 08:17AM Genprex and University of Pittsburgh Sign Exclusive License Agreement for Potentially Curative Gene Therapy Candidate for Diabetes
Feb 6, 2020 08:24AM Genprex (GNPX) Regains Compliance with Nasdaq Minimum Bid Price Requirement
Feb 6, 2020 08:17AM Genprex Regains Compliance with Nasdaq Minimum Bid Price Requirement
Feb 5, 2020 09:00AM Genprex to Focus Its Clinical Efforts on Oncoprex™ in Combination Therapy with Osimertinib for Non-Small Cell Lung Cancer (NSCLC)
Feb 3, 2020 08:17AM Genprex to Present at NobleCon16 Investor Conference
Jan 29, 2020 08:18AM Independent Researchers Find Genprex’s TUSC2 May Be a Novel Target and Biomarker for Thyroid Cancer Therapy
Jan 28, 2020 08:00AM Genprex, Inc. Announces Closing of $8 Million At-The-Market Common Stock Offering
Jan 23, 2020 09:01AM Genprex (GNPX) Prices 7.62M Share Common Offering at $1.05/Sh
Jan 23, 2020 09:00AM Genprex, Inc. Prices $8,000,000 Common Stock Offering Priced At-The-Market
Jan 21, 2020 08:01AM Genprex (GNPX) Granted FDA Fast Track Designation for Gene Therapy that Targets Lung Cancer
Jan 21, 2020 08:00AM Genprex Receives U.S. FDA Fast Track Designation for Gene Therapy that Targets Lung Cancer
Jan 6, 2020 08:00AM Genprex to Present at Biotech Showcase™ 2020 in San Francisco
Nov 20, 2019 11:16AM Genprex (GNPX) Announces $1.26 Million Registered Direct Offering
Nov 20, 2019 11:15AM Genprex Announces $1.26 Million Registered Direct Offering
Nov 19, 2019 08:07AM Genprex (GNPX) Reports Positive Preclinical Data for Treatment of Some of the Most Resistant Metastatic Lung Cancers
Nov 19, 2019 08:00AM Genprex Reports Positive Preclinical Data for the Treatment of Some of the Most Resistant Metastatic Lung Cancers
Nov 4, 2019 08:00AM Genprex Issues Lung Cancer Prevention Measures in Support of Lung Cancer Awareness Month
Oct 9, 2019 08:00AM Genprex to Present at the MicroCap Rodeo Investor Conference
Oct 7, 2019 08:00AM Genprex’s Pioneering Use of Non-Viral Delivery for Gene Therapy is Gaining Industry Support
Sep 26, 2019 08:30AM Genprex (GNPX) Featured in Audio Publication Discussing New Research on Breast Cancer Treatment
Sep 25, 2019 08:30AM Genprex (GNPX) Featured in Publication on Advances in Potential Breast Cancer Treatments
Sep 18, 2019 08:00AM Genprex to Present Via Webcast at the Singular Research Midwestern Values Conference on September 19, 2019
Sep 11, 2019 08:00AM Independent Researchers Find Genprex’s TUSC2 Prevents Tumor Growth in Triple-Negative Breast Cancer
Sep 7, 2019 04:35PM CORRECTING and REPLACING Genprex to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Sep 6, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Lung Cancer and Gene Therapy Treatments
Sep 6, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Lung Cancer and Gene Therapy Treatments
Sep 5, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsWire Publication Summarizing Gene Therapy Treatment for Lung Cancer
Sep 5, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsWire Publication Summarizing Gene Therapy Treatment for Lung Cancer
Sep 5, 2019 08:00AM Genprex to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Sep 3, 2019 08:00AM Genprex Provides Forward Looking Guidance and Updates on Corporate Activities, Publishes New Corporate Deck
Aug 23, 2019 08:30AM Genprex (GNPX) Featured in Broadcast Discussing Strength, Potential of Biotech Sector
Aug 23, 2019 08:30AM Genprex (GNPX) Featured in Broadcast Discussing Strength, Potential of Biotech Sector
Aug 22, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Company’s Milestone Achievements
Aug 22, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Company’s Milestone Achievements
Aug 21, 2019 08:00AM Genprex to Present at the RHK Capital 4th Annual Disruptive Growth Conference
Aug 13, 2019 08:00AM Genprex Demonstrates Growth and Expansion Through Recent Achievements
Aug 6, 2019 08:00AM Genprex™ Manufacturing Partner Aldevron Completes Significant Step in Manufacturing for Oncoprex™ Clinical Development Program
Jul 31, 2019 08:30AM Genprex Begins Next Phase of Drug Branding Program
Jul 1, 2019 08:30AM Genprex Provides Update on Development of its Oncoprex Immunogene Therapy in Combination with Immunotherapy for Non-Small Cell Lung Cancer
May 31, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Gene Therapy as Potential Cancer Treatment
May 31, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Gene Therapy as Potential Cancer Treatment
View More Recent Stories View Older Stories